Ippo nalla charayam okke ella flatilum vaatunnundu ennu kettoo..........
oru pakshe manorama teamsinulla sadhanam avarude officil thanne vaattunnudavum.......
Originally Posted by sachin
avide ake 12 alle death ayitullu barokke pootiyittum ivanmarkku poosakan ulla item evide ninnu kitunnu atho ini kanjavanu allathe ithupole ulla report engane padachu vidunne
sachin liked this post
| Sponsored Links ::::::::::::::::::::Remove adverts | |
Pandokke oru news vannal vishwasikkamayirunnu ippol vannal anweshichu urappu varuthenda gathikedanu readersinu iresponsible media reporting sensation undakkan enthum padachu vidam enna nilayilanu ivanmarkokke valla varkka panikkum poykoode....
Sathyam...
ithinokke nammude court swamedya case edukkanam
Tcr Shops elam restrictions vannu . Weekly once . Athum 9am - 3.30pm vare . Sunday mobile , inu hardware....
Innu Vanna News aano?
Inale mg , round , mo road shops elam adapichu . Police oder vanatila enu paranju . Police 1 akkam & 2akkam vechu vandikal pidikunud
ശ്വാസം, വിയർപ്പ്, തുപ്പൽ എന്നിവ മാത്രമല്ല, വളി വിടുന്നതിലൂടെയും രോഗം പടരുമെന്ന്.
Ahh...Townil checking point kooditundu, Last weeknekal checking koodi
Idukki today 3 More +ve cases
Very promising news!
The world's largest vaccine maker 'SERUM INSTITUTE OF INDIA' is producing 40 million units of the coronavirus vaccine currently on trial in Oxford
The world's largest vaccine maker is mass-producing a COVID-19 vaccine developed by the University of Oxford without knowing whether it works. Sarah Gilbert, a professor who is leading Oxford's attempt to develop a vaccine, said on April 11 that September was a realistic date to expect a vaccine that could work. "I think there's a high chance that it will work based on other things that we have done with this type of vaccine," she said.
The first two humans were injected with the vaccine on Thursday in Oxford, England. About 1,100 people in the UK are expected to be injected as part of the trial, which is funded by the UK government. "We may get enough data in a couple of months to see if the vaccine works, but if transmission levels drop, this could take up to six months," the group said on Thursday.
But Adar Poonawalla, the CEO of the Serum Institute of India, told The Times of India on Monday that he would not wait that long. Poonawalla previously told Business Insider India that his company would not patent the vaccine. "We don't want to make money from and commercialize something beyond a sustainable level in such a public-health epidemic," he said. "We are not waiting for the trials to get over in September in UK, and then start production here," he said. "The decision — at our own risk and cost — has been solely taken to get a jump-start on manufacturing, to have enough doses available, if the clinical trials prove successful.
"We are planning a set of animal trials [on mice and primates] of this vaccine in April. By September, we should be able to begin human trials," Adar Poonawalla, chief executive officer of Serum Institute of India, told me over the phone. Mr Poonawalla's firm has partnered to mass produce a vaccine being developed by the University of Oxford and backed by the UK government. A genetically engineered chimpanzee virus would form the basis for the new vaccine.
Serum Institute of India, is the world's largest vaccine maker by number of doses produced and sold globally. The 53-year-old company makes 1.5 billion doses every year, mainly from its two facilities in the western city of Pune and two other plants in the Netherlands and the Czech Republic. Around 7,000 people work for the firm.
"We aim to manufacture 4 to 5 million doses per month for the first six months, following which, we might scale up to 10 million doses per month, based on the success of trials. We are looking to build it up to 20-40 million doses by September-October. We are planning to make the vaccine available at an affordable price of around 1,000 rupees ($13) in India," he added. Drug prices vary widely around the world, and the same treatment often costs many times more in other countries."
US Secretary of State Mike Pompeo also said last fortnight that India and the US were working together to develop vaccines against the coronavirus. The two countries have run an internationally recognised joint vaccine development programme for more than three decades. They have worked on stopping dengue, enteric diseases, influenza and TB in their tracks. Trials of a dengue vaccine are planned in the near future.
India is among the largest manufacturer of generic drugs and vaccines in the world. It is home to half a dozen major vaccine makers and a host of smaller ones, making doses against polio, meningitis, pneumonia, rotavirus, BCG, measles, mumps and rubella, among other diseases. Now half a dozen Indian firms are developing vaccines against the virus that causes Covid-19.
https://www.businessinsider.com/indi...20-4?r=US&IR=T
https://www.bbc.co.uk/news/world-asia-india-52363791
Posting Permissions
Reply With Quote